p53-independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Singh, Sharon A ^a,b,c   Goldberg, Tracie A ^b,c   Henson, Adrianna L ^d   Husain Krautter, Sehba ^b   Nihrane, Abdallah ^b   Blanc, Lionel ^a,b,c   Ellis, Steven R ^d   Lipton, Jeffrey M ^a,b,c   Liu, Johnson M ^a,b,c  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c Northwell Health   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN RPL5; PROTEIN RPS19; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLACKFAN DIAMOND ANEMIA; CELL DAMAGE; CELL DIFFERENTIATION; COLONY FORMATION; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ERYTHROID CELL; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HAPLOINSUFFICIENCY; LIQUID CULTURE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RPL5 GENE; RPS19 GENE; TUMOR SUPPRESSOR GENE;

ANEMIA, DIAMOND-BLACKFAN; ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DNA PRIMERS; EMBRYONIC STEM CELLS; ERYTHROID CELLS; HAPLOINSUFFICIENCY; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84895892487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089098     Document Type: Article

References (48)

1. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, et al. (2008) Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 142: 859-876.
2. Lipton JM, Ellis SR (2009) Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am 23: 261-282.
3. Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM (2012) Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 119: 3815-3819.
4. Dianzani I, Loreni F (2008) Diamond-Blackfan anemia: a ribosomal puzzle. Haematologica 93: 1601-1604.
5. Lipton JM, Ellis SR (2010) Diamond Blackfan anemia 2008-2009: broadening the scope of ribosome biogenesis disorders. Curr Opin Pediatr 22: 12-19.
6. Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, et al. (2011) Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 118: 6943-6951.
7. Gazda HT, Zhong R, Long L, Niewiadomska E, Lipton JM, et al. (2004) RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol 127: 105-113. (Pubitemid 39331113)
8. Devlin EE, Dacosta L, Mohandas N, Elliott G, Bodine DM (2010) A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 116: 2826-2835.
9. Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, et al. (2008) Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83: 769-780.
10. Quarello P, Garelli E, Carando A, Brusco A, Calabrese R, et al. (2010) Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations. Haematologica 95: 206-213.
11. Sankaran VG, Ghazvinian R, Do R, Thiru P, Vergilio JA, et al. (2012) Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest 122: 2439-2443.
12. Weiss MJ, Mason PJ, Bessler M (2012) What's in a name? J Clin Invest 122: 2346-2349.
13. Sieff CA, Yang J, Merida-Long LB, Lodish HF (2010) Pathogenesis of the erythroid failure in Diamond Blackfan anaemia. Br J Haematol 148: 611-622.
14. Perdahl EB, Naprstek BL, Wallace WC, Lipton JM (1994) Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 83: 645-650. (Pubitemid 24043722)
15. Miyake K, Utsugisawa T, Flygare J, Kiefer T, Hamaguchi I, et al. (2008) Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia. Stem Cells 26: 323-329. (Pubitemid 351413591)
16. Kuramitsu M, Hamaguchi I, Takuo M, Masumi A, Momose H, et al. (2008) Deficient RPS19 protein production induces cell cycle arrest in erythroid progenitor cells. Br J Haematol 140: 348-359.
17. Ellis SR, Gleizes PE (2011) Diamond Blackfan anemia: ribosomal proteins going rogue. Semin Hematol 48: 89-96.
18. Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, et al. (2009) Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11: 501-508.
19. Horn HF, Vousden KH (2008) Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 27: 5774-5784.
20. Jin A, Itahana K, O'Keefe K, Zhang Y (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680. (Pubitemid 39121492)
21. Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, et al. (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 35: 316-326.
22. Yadavilli S, Mayo LD, Higgins M, Lain S, Hegde V, et al. (2009) Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain. DNA Repair (Amst) 8: 1215-1224.
23. McGowan KA, Mason PJ (2011) Animal models of Diamond Blackfan anemia. Semin Hematol 48: 106-116.
24. Chen WV, Soriano P (2003) Gene trap mutagenesis in embryonic stem cells. Methods Enzymol 365: 367-386. (Pubitemid 37531561)
25. Forrai A, Robb L (2005) The gene trap resource: a treasure trove for hemopoiesis research. Exp Hematol 33: 845-856. (Pubitemid 40982650)
26. Murry CE, Keller G (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680. (Pubitemid 351260059)
27. Palis J (2008) Ontogeny of erythropoiesis. Curr Opin Hematol 15: 155-161.
28. Choi K (1998) Hemangioblast development and regulation. Biochem Cell Biol 76: 947-956.
29. Keller G (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19: 1129-1155.
30. Wiles MV, Keller G (1991) Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111: 259-267. (Pubitemid 21920413)
31. Chan RJ, Hromas R, Yoder MC (2006) The role of Hex in hemangioblast and hematopoietic development. Methods Mol Biol 330: 123-133.
32. Montel-Hagen A, Blanc L, Boyer-Clavel M, Jacquet C, Vidal M, et al. (2008) The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood 112: 4729-4738.
33. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, et al. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16: 19-27. (Pubitemid 27198152)
34. Uechi T, Nakajima Y, Chakraborty A, Torihara H, Higa S, et al. (2008) Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia. Hum Mol Genet 17: 3204-3211.
35. Taylor AM, Humphries JM, White RM, Murphey RD, Burns CE, et al. (2012) Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp Hematol 40: 228-237.e225.
36. Garçon L, Ge J, Manjunath SH, Mills JA, Apicella M, et al. (2013) Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 122: 912-921.
37. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, et al. (2008) Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40: 963-970.
38. Jaako P, Flygare J, Olsson K, Quere R, Ehinger M, et al. (2011) Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 118: 6087-6096.
39. Danilova N, Sakamoto KM, Lin S (2008) Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112: 5228-5237.
40. Torihara H, Uechi T, Chakraborty A, Shinya M, Sakai N, et al. (2011) Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia. Br J Haematol 152: 648-654.
41. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, et al. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467. (Pubitemid 23252375)
42. Ganguli G, Back J, Sengupta S, Wasylyk B (2002) The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors. EMBO Rep 3: 569-574. (Pubitemid 34752458)
43. Sengupta S, Wasylyk B (2004) Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann N Y Acad Sci 1024: 54-71. (Pubitemid 38879593)
44. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, et al. (2011) Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 117: 2567-2576.
45. Badhai J, Fröjmark AS, J Davey E, Schuster J, Dahl N (2009) Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia. Biochim Biophys Acta 1792: 1036-1042.
46. Fumagalli S, Ivanenkov VV, Teng T, Thomas G (2012) Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 26: 1028-1040.
47. White J, Dalton S (2005) Cell cycle control of embryonic stem cells. Stem Cell Rev 1: 131-138. (Pubitemid 43074197)
48. Teng T, Mercer CA, Hexley P, Thomas G, Fumagalli S (2013) Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity. Mol Cell Biol 33: 4660-4671.